| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/19/2004 | CN1496742A Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1496737A Method for treating inflammation of muscular skeleton and connective tissue |
| 05/19/2004 | CN1150206C Bradykinin antagonist peptides incorporating N-substituted glycines |
| 05/19/2004 | CN1150205C 3-mercaptoacetylamino-1,5-subsd.2-oxo-axepon derivatives useful as inhibitor of metrix metalloproteinaes |
| 05/19/2004 | CN1150195C Bicyclic nitrogen heterocycles |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/19/2004 | CN1150006C Beetoxin injection and its preparing process |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737435 Indole derivatives and their use as MCP-1 antagonist |
| 05/18/2004 | US6737426 Such as (4-phenylsulfonyl-2-pyridin-3-yl-oxazol-5-yl)-methylamine; anticonvulsants, antiinflammatories, neuro-protectants, cerebroprotectants, nootropics |
| 05/18/2004 | US6737421 4-carboxyamido substituted; neurodegenerative diseases; neuronal damage |
| 05/18/2004 | US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof |
| 05/18/2004 | US6737399 Using histacalin protein isolated from ticks |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737059 Methods of inhibiting inflammatory processes and alleviating symptoms associated with multiple sclerosis |
| 05/18/2004 | US6737042 Delivery of drug esters through an inhalation route |
| 05/18/2004 | CA2301742C 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
| 05/13/2004 | WO2004040302A1 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 05/13/2004 | WO2004039978A2 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/13/2004 | WO2004039972A1 H17t213-transgenic animal, novel h17t213 protein and dna thereof |
| 05/13/2004 | WO2004039841A2 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | WO2004039821A1 9a-azalides with anti-inflammatory activity |
| 05/13/2004 | WO2004039807A1 Pyridopyrrolizine and pyridoindolizine derivatives |
| 05/13/2004 | WO2004039806A1 Heterocyclic compounds |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039753A2 Phenyl compounds |
| 05/13/2004 | WO2004039409A2 Composition comprising activators of ik potassium channels and calcineurin antagonists and use thereof |
| 05/13/2004 | WO2004039391A1 Viral serpin regulation of inflamation |
| 05/13/2004 | WO2004039378A1 Preparations comprising 1,3 and/or 1,6 beta glucans for the treatment of infections and inflammations in animals |
| 05/13/2004 | WO2004039377A1 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 05/13/2004 | WO2004039371A2 Compositions of cyclooxygenase-2 selective inhibitors and nmda receptor antagonists for the treatment or prevention of neuropathic pain |
| 05/13/2004 | WO2004039358A1 Adhesive composition for dermal patch and production process thereof |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004022102A3 Pharmaceutical formulation with non-steroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells |
| 05/13/2004 | WO2004009542A3 Process for preparing certain pyrrolotriazine compounds |
| 05/13/2004 | WO2004005293A3 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003090684B1 Polymer compositions containing a macrocyclic triene compound |
| 05/13/2004 | WO2003080022A3 Analgesics for nasal administration |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003077830A3 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003059194A3 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 05/13/2004 | WO2003035000A3 Method for treating non-neuropathic pain |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2002024146A9 Methods of decreasing or preventing pain using spicamycin derivatives |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092595 Analgesic agent |
| 05/13/2004 | US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/13/2004 | US20040092582 Antiinflammatory agents; respiratory system disorders; antiarthritic agents; autoimmune diseases; antidiabetic agents |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092566 Cyclooxygenase inhibitors; antiinflammatory agents, antipyretics, analgesics |
| 05/13/2004 | US20040092562 Methods for treating inflammatory conditions or inhibiting JNK |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092519 New treatment for hot flashes |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/13/2004 | US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents |
| 05/13/2004 | US20040092486 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 05/13/2004 | US20040092458 Administering a Free-B-Ring flavonoid as cyclooxygenase-2 (COX-2) inhibitor to treat osteoarthritis, rheumatoid arthritis, menstrual cramps, Systemic Lupus Erythromatosis, psoriasis, migraines, inflammatory bowel disease, cancer |
| 05/13/2004 | US20040092455 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040092430 Antitumor agents; antiinflammatory agents; autoimmune disease |
| 05/13/2004 | US20040091912 Diagnostic method |
| 05/13/2004 | US20040091545 Entrapping the acid in a methacrylic acid copolymer by acidifying a basic solution or dispersion to cause formation of a precipitate which is then collected and dried; odorless dietary supplement for cardio-vascular systems |
| 05/13/2004 | US20040091508 Rapidly absorbed liquid compositions |
| 05/13/2004 | US20040091507 Rapidly absorbed liquid compositions |
| 05/13/2004 | US20040091501 Immunosuppresor agent derived from morbillivirus |
| 05/13/2004 | US20040091478 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/13/2004 | US20040091476 Enhance or suppress T-cell activation and proliferation |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091458 Method for reducing pain using oncolytic viruses |
| 05/13/2004 | DE10250870A1 Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung Composition containing activators of IK potassium channels and calcineurin antagonists and their use |
| 05/13/2004 | CA2503697A1 Trimeric binding proteins for trimeric cytokines |
| 05/13/2004 | CA2500850A1 Use of piperazine sulfonic acid derivatives as ccr1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders |
| 05/12/2004 | EP1418431A1 Nuclear pore protein Nup88 as a novel target |
| 05/12/2004 | EP1418234A1 Human monoclonal antibodies against oxidized ldl receptor and medicinal use thereof |
| 05/12/2004 | EP1417963A1 Highly purified EPA and derivatives for psychiatric and neurological disorders |
| 05/12/2004 | EP1417328A2 Invasion complex and methods of targeting |
| 05/12/2004 | EP1417307A2 Oligonucleotide compositions and their use to induce apoptosis |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417224A2 Secreted proteins |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417201A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |